BAMCO Inc’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$64.6M Buy
548,346
+3,567
+0.7% +$498K 0.2% 88
2025
Q4
$89.3M Buy
544,779
+163,101
+43% +$25.5M 0.24% 78
2025
Q3
$51M Buy
381,678
+107,235
+39% +$13M 0.14% 134
2025
Q2
$34.1M Buy
274,443
+69,474
+34% +$8.84M 0.09% 167
2025
Q1
$26.1M Buy
204,969
+44,742
+28% +$6.89M 0.08% 182
2024
Q4
$23.1M Sell
160,227
-6,792
-4% -$974K 0.06% 189
2024
Q3
$24.9M Sell
167,019
-5,495
-3% -$788K 0.07% 189
2024
Q2
$21.7M Sell
172,514
-208,772
-55% -$32.7M 0.06% 195
2024
Q1
$70.1M Sell
381,286
-64,472
-14% -$12.3M 0.19% 106
2023
Q4
$80.1M Sell
445,758
-13,026
-3% -$2.03M 0.21% 90
2023
Q3
$73M Buy
458,784
+99,763
+28% +$16.3M 0.21% 83
2023
Q2
$50.8M Buy
359,021
+138,047
+62% +$22.1M 0.14% 125
2023
Q1
$37.2M Buy
220,974
+212,374
+2,469% +$37.9M 0.11% 145
2022
Q4
$1.46M Buy
8,600
+1,800
+26% +$326K ﹤0.01% 321
2022
Q3
$1.27M Buy
+6,800
New +$1.43M ﹤0.01% 325

Other funds holding RGEN

BAMCO Inc's RGEN Position: Q1 2026 in Review

BAMCO Inc increased its Repligen (RGEN) stake by 0.65% in Q1 2026, buying an estimated $498K and bringing the position to 548,346 shares worth $64.6M. The position accounts for 0.2% of the portfolio, ranked #88.

BAMCO Inc first reported a position in RGEN in Q3 2022 and has held it in 15 quarters since. The position peaked at $89.3M in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • BAMCO Inc held 548,346 shares of Repligen worth $64.6M as of Q1 2026.
  • BAMCO Inc bought 3,567 Repligen shares in Q1 2026, an estimated $498K.
  • Repligen made up 0.2% of BAMCO Inc's portfolio in Q1 2026, its #88 holding.
  • BAMCO Inc first reported a position in Repligen in Q3 2022 and has held it in 15 quarters since.
  • BAMCO Inc's Repligen position peaked at $89.3M in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on BAMCO Inc's 13F filing for Q1 2026, filed 15 May 2026.